Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Probiotics · Rheumatoid Arthritis Trial completed Ancilia BiosciencesNot applicable NCT07304505
  2. Minor: Tolerance of a New Formula Based on Hydrolyzed Rice Proteins · Cow's Milk Allergy Trial completed Health and Happiness Research LimitedNot applicable NCT07197814
  3. Minor: User Experience of BP-CBB Trial completed Bactolife A/SNot applicable NCT07628608
  4. Minor: Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance Trial completed Sofwave Medical LTDNot applicable NCT06724146
  5. Minor: Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer · Different Histologies Trial status changed: Not Yet Recruiting → Active, Not Recruiting PfizerNot specified NCT07897669
  6. Minor: Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses Trial completed Unicon Optical Co. Ltd.Not applicable NCT07322211
  7. Minor: Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care · Previously Treated Multiple Myeloma Primary completion pushed from Oct 31, 2028 to Nov 30, 2028 Hoffmann-La RochePhase 3 NCT07555938
  8. Minor: AND017 to Evaluate Efficacy and Safety · Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Primary completion pushed from Dec 1, 2026 to Mar 1, 2027 Kind Pharmaceuticals LLCPhase 3 NCT07487727
  9. Minor: Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients Trial completed Tanta UniversityPhase 3 NCT05669742
  10. Minor: TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb) Primary completion pushed from Jun 27, 2026 to Dec 14, 2026 Beijing Tide Pharmaceutical Co., LtdPhase 2 NCT07543796
  11. Minor: Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) Enrollment closed, study ongoing Hellenic Institute for the Study of SepsisPhase 3 NCT06294600
  12. Minor: Multiple-Ascending-Dose Study of XTMAB-16 · Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations Primary and study completion pushed from Oct 31, 2026 to Nov 30, 2026 Xentria, Inc.Phase 1/2 NCT05890729
  13. Minor: Deep Learning for Musculoskeletal Complications in Breast Cancer Trial completed Ankara Etlik City HospitalNot specified NCT07236658
  14. Minor: Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies Trial completed First Affiliated Hospital of Zhejiang UniversityPhase 3 NCT04547049
  15. Minor: Artemis Sleep Countermeasures Trial status changed: Unknown → Completed National Aeronautics and Space Administration (NASA)Not applicable NCT06531733
  16. Minor: Live Parent-Child Video Interaction and Cartoon Watching for Emergence Agitation in Children Trial completed Izmir City HospitalNot applicable NCT07689305
  17. Minor: VA vs DA for Newly Diagnosed Hig-risk AML Enrollment closed, study ongoing The First Affiliated Hospital of Soochow UniversityPhase 2/3 NCT05939180
  18. Minor: Mosunetuzumab Monotherapy · Select B-Cell Malignancies Primary completion pushed from Jul 31, 2027 to Oct 1, 2027 Genentech, Inc.Phase 2 NCT05207670
  19. Minor: Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy Enrollment closed, study ongoing M.D. Anderson Cancer CenterPhase 2/3 NCT05431595
  20. Minor: Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA) Enrollment closed, study ongoing NHS National Waiting Times Centre BoardPhase 2 NCT05198791
  21. Minor: Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors Enrollment closed, study ongoing Samsung Medical CenterPhase 2 NCT07381231
  22. Minor: LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention Trial completed Alexandra Hospital, Athens, GreecePhase 4 NCT07361679
  23. Minor: Efsubaglutide Alfa in Overweight/Obesity(SPARKLE) Trial completed Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Phase 2 NCT07114419
  24. Minor: Perioperative Use of Erector Spinae Plane Block (ESPB) and Intravenous Lidocaine Infusion in Anesthetic Management of Spinal Surgery in Children Trial completed Saint Petersburg State University, RussiaPhase 4 NCT06965933
  25. Minor: Vitamin A and D Supplementation in Allogeneic HCT Enrollment closed, study ongoing St. Petersburg State Pavlov Medical UniversityPhase 2 NCT06508099